When it comes to how consumers seek and consume healthcare information, the generational divide between Generation Z, millennials and boomers may not be as wide as you’d think.
That’s according to CMI Media Group’s latest Media Vitals annual report, which bucks some of the conventional wisdom about how to market healthcare products to different age groups. The report, based on an online survey of 2,000 consumers, examined what healthcare consumers want and need from life science manufacturers.
The upshot for pharma marketers? Don’t rely on outdated assumptions, Brian Wagner, CMI’s vice president for product development, said in an interview.
“I’m not saying a senior boomer is going to be just like a Gen Z and vice versa,” he said. “But we’re seeing that generational gap getting smaller.”
For example, one common stereotype is that seniors aren’t digitally savvy. But Wagner said the pandemic pushed many older adults to quickly learn new technology, like how to stream a movie on Netflix or navigate a telehealth visit with their doctor.
So, instead of discounting digital platforms as a way to reach them, pharma marketers should try to understand their individual preferences, Wagner said.
“As a 55-year-old GenXer, you’re not going to find me anytime soon sitting on my couch watching a movie on this,” he said, holding up his smartphone. “But the fact that I can use Alexa to access my Pandora app to get good dinner music, that’s something else.”
Consumers, regardless of age, are putting more trust in health websites like WebMD than they have in the past, the report found. Of particular note to pharma companies, branded websites saw the biggest trust gains across all age groups, and especially among millennials, nearly half of whom cited brand sites as a “trusted source.”
Wagner credited the pandemic for raising the profile of the industry and health agencies like the Centers for Disease Control and Prevention and the FDA. “They’re part of our normal dinner table conversation,” he said.
The doctor’s office, nonetheless, remains the go-to source for health information across all age groups. It was cited by 42% of millennials (ages 25-40) and 50% of baby boomers (ages 57-75). Email is the second choice for both groups, at 28% and 37%, respectively.
The difference, though, is that older consumers are more likely to say they follow their doctors’ orders (69% for people over 75 versus 33% of 18- to 24-year-olds). Younger patients are more likely to supplement information they get from HCPs with their own research.
While the report found only 3% of boomers want to get their healthcare information from social media (compared to 28% of Gen Z and and 21% of millennials), it suggests drugmakers shouldn’t ignore places like Twitter and Facebook when targeting older consumers.
Given the sheer size of that age group, that can still be a lot of eyes on ads, the report points out.
by Natalie Missakian
Source: fiercepharma.com
Giovanni Caforio, the former CEO of Bristol Myers Squibb, is set to become the next board chairman of Novartis, which on Tuesday proposed the pharmaceutical industry veteran as its pick to replace Joerg Reinhardt in the role next year. Reinhardt has served as Novartis’ chair since 2013 and plans to retire when his 12-year term ends in 2025.
GE HealthCare has raised the curtain on two ultrasound systems equipped with artificial intelligence programs designed to assist in diagnosing conditions in women’s health, including obstetric exams. The Voluson Signature 20 and 18 imaging systems include AI tools capable of automatically identifying and annotating measurements of fetal anatomy.
Scientists from the University of Edinburgh’s School of Chemistry have revealed a new sustainable method of manufacturing complex molecules that could reduce waste produced during drug production. The method published in Nature Chemistry could help to prevent severe side effects caused by drugs that can exist as enantiomers.
